Home LiteratureArticle Details
PMID: 19042931 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

Brain : a journal of neurology ·Vol. 132 ·No. Pt 5 ·2009-05-00 ·Pages 1310-23

Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative

Abstract

Although beta-amyloid (Abeta) plaques are a primary diagnostic criterion for Alzheimer's disease, this pathology is commonly observed in the brains of non-demented older individuals. To explore the importance of this pathology in the absence of dementia, we compared levels of amyloid deposition (via 'Pittsburgh Compound-B' (PIB) positron emission tomography (PET) imaging) to hippocampus volume (HV) and episodic memory (EM) in three groups: (i) normal controls (NC) from the Berkeley Aging Cohort (BAC NC, n = 20); (ii) normal controls (NC) from the Alzheimer's disease neuroimaging initiative (ADNI NC, n = 17); and (iii) PIB+ mild cognitive impairment subjects from the ADNI (ADNI PIB+ MCI, n = 39). Age, gender and education were controlled for in each statistical model, and HV was adjusted for intracranial volume (aHV). In BAC NC, elevated PIB uptake was significantly associated with smaller aHV (P = 0.0016) and worse EM (P = 0.0086). Within ADNI NC, elevated PIB uptake was significantly associated with smaller aHV (P = 0.047) but not EM (P = 0.60); within ADNI PIB+ MCI, elevated PIB uptake was significantly associated with both smaller aHV (P = 0.00070) and worse EM (P = 0.046). To further understand these relationships, a recursive regression procedure was conducted within all ADNI NC and PIB+ MCI subjects (n = 56) to test the hypothesis that HV mediates the relationship between Abeta and EM. Significant correlations were found between PIB index and EM (P = 0.0044), PIB index and aHV (P < 0.0001), as well as between aHV and EM (P < 0.0001). When both aHV and PIB were included in the same model to predict EM, aHV remained significant (P = 0.0015) whereas PIB index was no longer significantly associated with EM (P = 0.50). These results are consistent with a model in which Abeta deposition, hippocampal atrophy, and EM occur sequentially in elderly subjects, with Abeta deposition as the primary event in this cascade. This pattern suggests that declining EM in older individuals may be caused by Abeta-induced hippocampus atrophy.

MeSH Terms
Age Factors Aged Aging/physiology Alzheimer Disease/diagnostic imaging,pathology,psychology Amyloid beta-Peptides/analysis Aniline Compounds Atrophy Carbon Radioisotopes Case-Control Studies Educational Status Female Hippocampus/chemistry,diagnostic imaging,pathology Humans Linear Models Magnetic Resonance Imaging Male Memory Disorders/diagnostic imaging,pathology,psychology Middle Aged Multivariate Analysis Organ Size Positron-Emission Tomography/methods Psychiatric Status Rating Scales Radiopharmaceuticals Sex Factors Thiazoles
Chemicals
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole Amyloid beta-Peptides Aniline Compounds Carbon Radioisotopes Radiopharmaceuticals Thiazoles
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Mormino E C
Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA. [email protected]
Kluth J T
Madison C M
Rabinovici G D
Baker S L
Miller B L
Koeppe R A
Mathis C A
Weiner M W
Jagust W J
Alzheimer's Disease Neuroimaging Initiative
Investigators
206 investigators, click to expand
Weiner Michael
Thal Leon
Weiner Michael
Thal Leon
Petersen Ronald
Jack Clifford R
Jagust William
Trojanowki John
Toga Arthur W
Beckett Laurel
Green Robert C
Gamst Anthony
Potter William Z
Green Robert C
Montine Tom
Petersen Ronald
Thal Leon
Jack Clifford R
Anders Dale
Bernstein Matthew
Felmlee Joel
Fox Nick
Thompson Paul
Schuff Norbert
Alexander Gene
Jagust William
Bandy Dan
Koeppe Robert A
Foster Norm
Reiman Eric M
Chen Kewei
Trojanowki John
Shaw Les
Lee Virginia M-Y
Korecka Magdalena
Toga Arthur W
Crawford Karen
Neu Scott
Beckett Laurel
Harvey Danielle
Gamst Anthony
Kornak John
Kachaturian Zaven
Frank Richard
Snyder Peter J
Molchan Susan
Kaye Jeffrey
Vorobik Remi
Quinn Joseph
Schneider Lon
Pawluczyk Sonia
Spann Bryan
Fleisher Adam S
Vanderswag Helen
Heidebrink Judith L
Lord Joanne L
Petersen Ronald
Johnson Kris
Doody Rachelle S
Villanueva-Meyer Javier
Chowdhury Munir
Stern Yaakov
Honig Lawrence S
Bell Karen L
Morris John C
Mintun Mark A
Schneider Stacy
Marson Daniel
Griffith Randall
Badger Beverly
Grossman Hillel
Tang Cheuk
Stern Jessica
deToledo-Morrell Leyla
Shah Raj C
Bach Julie
Duara Ranjan
Isaacson Richard
Strauman Silvia
Albert Marilyn S
Pedroso Julia
Toroney Jaimie
Rusinek Henry
de Leon Mony J
De Santi Susan M
Doraiswamy P Murali
Petrella Jeffrey R
Aiello Marilyn
Clark Christopher M
Pham Cassie
Nunez Jessica
Smith Charles D
Given Curtis A
Hardy Peter
DeKosky Steven T
Oakley MaryAnn
Simpson Donna M
Ismail M Saleem
Porsteinsson Anton
McCallum Colleen
Cramer Steven C
Mulnard Ruth A
McAdams-Ortiz Catherine
Diaz-Arrastia Ramon
Martin-Cook Kristen
DeVous Michael
Levey Allan I
Lah James J
Cellar Janet S
Burns Jeffrey M
Anderson Heather S
Laubinger Mary M
Bartzokis George
Silverman Daniel H S
Lu Po H
Fletcher Rita
Parfitt Francine
Johnson Heather
Farlow Martin
Herring Scott
Hake Ann M
van Dyck Christopher H
MacAvoy Martha G
Bifano Laurel A
Chertkow Howard
Bergman Howard
Hosein Chris
Black Sandra
Graham Simon
Caldwell Curtis
Feldman Howard
Assaly Michele
Hsiung Ging-Yuek R
Kertesz Andrew
Rogers John
Trost Dick
Bernick Charles
Gitelman Darren
Johnson Nancy
Mesulam Marsel
Sadowsky Carl
Villena Teresa
Mesner Scott
Aisen Paul S
Johnson Kathleen B
Behan Kelly E
Sperling Reisa A
Rentz Dorene M
Johnson Keith A
Rosen Allyson
Tinklenberg Jared
Ashford Wes
Sabbagh Marwan
Connor Donald
Obradov Sanja
Green Robert C
Killiany Ron
Norbash Alex
Obisesan Thomas O
Jayam-Trouth Annapurni
Wang Paul
Auchus Alexander P
Huang Juebin
Friedland Robert P
DeCarli Charles
Fletcher Evan
Carmichael Owen
Kittur Smita
Mirje Seema
Johnson Sterling C
Borrie Michael
Lee T-Y
Asthana Sanjay
Carlsson Cynthia M
Potkin Steven G
Highum Diane
Preda Adrian
Nguyen Dana
Tariot Pierre N
Reiman Eric M
Hendin Barry A
Scharre Douglas W
Kataki Maria
Beversdorf David Q
Zimmerman Earl A
Celmins Dzintra
Brown Alice D
Gandy Sam
Marenberg Marjorie E
Rovner Barry W
Pearlson Godfrey
Blank Karen
Anderson Karen
Saykin Andrew J
Santulli Robert B
Pare Nadia
Williamson Jeff D
Sink Kaycee M
Potter Huntington
Raj B Ashok
Giordano Amy
Ott Brian R
Wu Chuang-Kuo
Cohen Ronald
Wilks Kerri L
Safirstein Beth E
References (63)
63 references, click to expand
  1. Production of [11C]CH3I by single pass reaction of [11C]CH4 with I2.
    Nucl Med Biol. 1997 Jan;24(1):93-7 PMID: 9080480
  2. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
    Neuropsychologia. 2008;46(6):1688-97 PMID: 18343463
  3. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Arch Neurol. 2006 May;63(5):693-9 PMID: 16682538
  4. Neuropathological stageing of Alzheimer-related changes.
    Acta Neuropathol. 1991;82(4):239-59 PMID: 1759558
  5. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
    Brain. 2007 Oct;130(Pt 10):2607-15 PMID: 17698496
  6. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease.
    J Int Neuropsychol Soc. 2008 Mar;14(2):266-78 PMID: 18282324
  7. A beta oligomers - a decade of discovery.
    J Neurochem. 2007 Jun;101(5):1172-84 PMID: 17286590
  8. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.
    J Pers Soc Psychol. 1986 Dec;51(6):1173-82 PMID: 3806354
  9. PET imaging of amyloid deposition in patients with mild cognitive impairment.
    Neurobiol Aging. 2008 Oct;29(10):1456-65 PMID: 17499392
  10. Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET.
    Neuroimage. 2006 Oct 1;32(4):1591-607 PMID: 16828315
  11. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
    Neurology. 1984 Jul;34(7):939-44 PMID: 6610841
  12. Neuropathology of cognitively normal elderly.
    J Neuropathol Exp Neurol. 2003 Nov;62(11):1087-95 PMID: 14656067
  13. Brain structural alterations before mild cognitive impairment.
    Neurology. 2007 Apr 17;68(16):1268-73 PMID: 17438217
  14. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.
    Ann Neurol. 1999 Mar;45(3):358-68 PMID: 10072051
  15. Frequent amyloid deposition without significant cognitive impairment among the elderly.
    Arch Neurol. 2008 Nov;65(11):1509-17 PMID: 19001171
  16. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.
    Ann Neurol. 2006 Mar;59(3):512-9 PMID: 16372280
  17. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.
    Nature. 2008 Feb 7;451(7179):720-4 PMID: 18256671
  18. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Brain. 2008 Mar;131(Pt 3):665-80 PMID: 18263627
  19. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.
    Ann Neurol. 1988 Feb;23(2):138-44 PMID: 2897823
  20. Comparative evaluation of MR-based partial-volume correction schemes for PET.
    J Nucl Med. 1999 Dec;40(12):2053-65 PMID: 10616886
  21. Differential aging of the brain: patterns, cognitive correlates and modifiers.
    Neurosci Biobehav Rev. 2006;30(6):730-48 PMID: 16919333
  22. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.
    J Med Chem. 2003 Jun 19;46(13):2740-54 PMID: 12801237
  23. Effects of adult age on structural and operational capacities in working memory.
    Psychol Aging. 1991 Mar;6(1):118-27 PMID: 2029360
  24. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.
    Ann Neurol. 2008 Jan;63(1):112-8 PMID: 18023012
  25. Correction for head size in brain-imaging measurements.
    Psychiatry Res. 1993 Jun;50(2):121-39 PMID: 8378488
  26. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Science. 2002 Jul 19;297(5580):353-6 PMID: 12130773
  27. Distribution volume ratios without blood sampling from graphical analysis of PET data.
    J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40 PMID: 8784228
  28. Selective decline in memory function among healthy elderly.
    Neurology. 1999 Apr 22;52(7):1392-6 PMID: 10227623
  29. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.
    J Neuropathol Exp Neurol. 1998 Dec;57(12):1168-74 PMID: 9862640
  30. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.
    J Magn Reson Imaging. 2008 Apr;27(4):685-91 PMID: 18302232
  31. Cortical surface-based analysis. I. Segmentation and surface reconstruction.
    Neuroimage. 1999 Feb;9(2):179-94 PMID: 9931268
  32. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease.
    Cogn Behav Neurol. 2003 Dec;16(4):211-8 PMID: 14665820
  33. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
    Neuroimage. 2006 Jul 1;31(3):968-80 PMID: 16530430
  34. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.
    Brain. 2007 Nov;130(Pt 11):2837-44 PMID: 17928318
  35. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.
    Neurology. 2002 Mar 12;58(5):750-7 PMID: 11889239
  36. In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease.
    Ann N Y Acad Sci. 1996 Jan 17;777:1-13 PMID: 8624070
  37. Frequency of stages of Alzheimer-related lesions in different age categories.
    Neurobiol Aging. 1997 Jul-Aug;18(4):351-7 PMID: 9330961
  38. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
    Arch Neurol. 2006 May;63(5):674-81 PMID: 16682537
  39. "Preclinical" AD revisited: neuropathology of cognitively normal older adults.
    Neurology. 2000 Aug 8;55(3):370-6 PMID: 10932270
  40. Cognitive reserve and Alzheimer disease.
    Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3 Suppl 2):S69-74 PMID: 16917199
  41. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.
    Neurology. 2006 Aug 8;67(3):446-52 PMID: 16894106
  42. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Neurology. 2006 Jun 27;66(12):1837-44 PMID: 16801647
  43. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
    Neurology. 1999 Apr 22;52(7):1397-403 PMID: 10227624
  44. Synthesis of L- and D-[methyl-11C]methionine.
    J Nucl Med. 1987 Jun;28(6):1037-40 PMID: 3585494
  45. Functional connectivity with the hippocampus during successful memory formation.
    Hippocampus. 2005;15(8):997-1005 PMID: 16281291
  46. Imaging beta-amyloid burden in aging and dementia.
    Neurology. 2007 May 15;68(20):1718-25 PMID: 17502554
  47. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample.
    Arch Neurol. 2000 Jun;57(6):839-44 PMID: 10867781
  48. Alzheimer neuropathologic alterations in aged cognitively normal subjects.
    J Neuropathol Exp Neurol. 1999 Apr;58(4):376-88 PMID: 10218633
  49. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex.
    IEEE Trans Med Imaging. 2001 Jan;20(1):70-80 PMID: 11293693
  50. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume.
    Neuroimage. 2004 Oct;23(2):724-38 PMID: 15488422
  51. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.
    Arch Neurol. 2008 Jan;65(1):113-20 PMID: 18195148
  52. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.
    Neurology. 2006 Nov 14;67(9):1575-80 PMID: 16971697
  53. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.
    Neuron. 2002 Jan 31;33(3):341-55 PMID: 11832223
  54. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
    J Cereb Blood Flow Metab. 2005 Nov;25(11):1528-47 PMID: 15944649
  55. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
    Arch Neurol. 2004 Mar;61(3):378-84 PMID: 15023815
  56. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI.
    Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4637-42 PMID: 15070770
  57. Observations on the brains of non-demented old people.
    J Neurol Sci. 1968 Sep-Oct;7(2):331-56 PMID: 5707082
  58. The Clinical Dementia Rating (CDR): current version and scoring rules.
    Neurology. 1993 Nov;43(11):2412-4 PMID: 8232972
  59. Absence of cognitive impairment or decline in preclinical Alzheimer's disease.
    Neurology. 2001 Feb 13;56(3):361-7 PMID: 11171902
  60. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI.
    Neuroimage. 2006 Jun;31(2):496-504 PMID: 16473024
  61. A hybrid approach to the skull stripping problem in MRI.
    Neuroimage. 2004 Jul;22(3):1060-75 PMID: 15219578
  62. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
    Ann Neurol. 2004 Mar;55(3):306-19 PMID: 14991808
  63. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.
    Cereb Cortex. 1991 Jan-Feb;1(1):103-16 PMID: 1822725
Article Info
Journal
Brain : a journal of neurology
Abbr.
Brain
ISSN
1460-2156
Published
2009-05-00
Epub
2008-00-28
Pages
1310-23
Language
English
Region
England
NLM ID
0372537
PMCID
PMC2677792
Subset
IM
Grants
NIA NIH HHS · R01 AG027859 · United States
NIA NIH HHS · P30 AG019610 · United States
NIA NIH HHS · R01 AG027859-02 · United States
NIA NIH HHS · R01 AG034570 · United States
NIA NIH HHS · P50 AG023501 · United States
NIA NIH HHS · AG024904 · United States
NIA NIH HHS · R01 AG027342 · United States
NIA NIH HHS · U01 AG024904 · United States
NIA NIH HHS · U19 AG010483 · United States
NIA NIH HHS · K23 AG031861 · United States
NIA NIH HHS · AG027859 · United States
Medical Research Council · G0601846 · United Kingdom
NIA NIH HHS · P01 AG010491-14 · United States
NIA NIH HHS · P01 AG010491 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]